Ryunosuke Machida

1.4k citations
65 papers · 707 · 2 hit papers · h-index 10

Impact in

  • Neurology top 10%
    • Myasthenia Gravis and Thymoma
    • Neuroblastoma Research and Treatments
  • Surgery top 10%
    • Esophageal Cancer Research and Treatment
    • Esophageal and GI Pathology
    • Reconstructive Facial Surgery Techniques

Papers in

    • Esophageal Cancer Research and Treatment 16
    • Esophageal and GI Pathology 4
    • Gastric Cancer Management and Outcomes 11
    • Sarcoma Diagnosis and Treatment 5
    • Lung Cancer Treatments and Mutations 5

Ryunosuke Machida

51 papers receiving 686 citations

Ryunosuke Machida's Hit Papers

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2–Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial 2023 · 89 citations
890+1+2Years since publication4080120

Peers

Ryunosuke Machida
Comparison fields: 5 of 65
  • Neurology 130
  • Surgery 269
  • Oncology 154
  • Obstetrics and Gynecology 35
  • Pulmonary and Respiratory Medicine 151
Replace Kou Kaneko with:
Kou Kaneko Japan
Jorge Dotto United States
Marta Braschi‐Amirfarzan United States
Edina Paál United States
Jorge Torres‐Mora United States
Květoslava Michalová Czechia
Thomas Brodowicz Austria
Elisabetta Froio Italy
J.P. Gérard France
Giuseppe Ciancia Italy
Ryunosuke Machida relative to Kou Kaneko Japan Kou Kaneko's profile →
Citations per field
00.5×10×15×21.9×
Kou Kaneko · 1×
Citations per year

Countries citing papers authored by Ryunosuke Machida

Since Specialization
Citations

This map shows the geographic impact of Ryunosuke Machida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryunosuke Machida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryunosuke Machida more than expected).

Fields of papers citing papers by Ryunosuke Machida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryunosuke Machida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryunosuke Machida. The network helps show where Ryunosuke Machida may publish in the future.

Co-authors

The 25 scholars most cited alongside Ryunosuke Machida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryunosuke Machida Line = papers co-authored together Ryunosuke Machida links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2020140
2
A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study.
Hit paper breakdown →
2022130
3
Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2–Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial
Hit paper breakdown →
202389
4 202057
5 196541
6 202234
7 196530
8 202019
9 202112
10 202410
11 20209
12 20248
13 20238
14 20208
15 20217
16 20187
17 20237
18 20197
19 20217
20 20236

About Ryunosuke Machida

Ryunosuke Machida is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Otorhinolaryngology and Pathology and Forensic Medicine, having authored 65 papers that have together received 707 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (16 papers), Gastric Cancer Management and Outcomes (11 papers), Head and Neck Cancer Studies (6 papers), Sarcoma Diagnosis and Treatment (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers), Myasthenia Gravis and Thymoma (4 papers) and Esophageal and GI Pathology (4 papers). The work is most often cited by research in Neurology (130 citations), Surgery (269 citations), Oncology (154 citations), Obstetrics and Gynecology (35 citations) and Pulmonary and Respiratory Medicine (151 citations). Ryunosuke Machida has collaborated with scholars based in Japan, United States and India. Frequent co-authors include Kenichi Nakamura, Yuko Kitagawa, Ken Kato, Yoshinori Ito, Masaya Watanabe, Duncan McConnell, Franklin L. Ashley, Frederick M. Grazer, Noboru Yamamoto and Hidenori Mizugaki. Their work appears in journals such as Japanese Journal of Clinical Oncology, Journal of Clinical Oncology, Annals of Surgical Oncology, Statistics in Medicine and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact